Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age
Clinical trial NCT02879266 · COMPLETED
Trial details
- NCT number
- NCT02879266
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2017-09-07
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.